Literature DB >> 7436560

HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients.

H Yazici, M A Chamberlain, I Schreuder, J D'Amaro, M Muftuoglu.   

Abstract

We have compared the distribution of histocompatibility antigens of 22 Turkish and 14 British patients with Behçet's disease with those of their respective controls. There was a strong association of B5, specifically its Bw51 split, with the disease. A modest increase in the incidence of HLA B27 was noted in British patients, but numbers were too small for analysis. The incidence of DRw2 and DRw4 antigens among Turkish and British patients did not differ from that of their respective controls.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436560      PMCID: PMC1000554          DOI: 10.1136/ard.39.4.344

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  The estimation and significance of the logarithm of a ratio of frequencies.

Authors:  J B HALDANE
Journal:  Ann Hum Genet       Date:  1956-05       Impact factor: 1.670

3.  HL-A antigens in Behcet's disease.

Authors:  J D O'Duffy; H F Taswell; L R Elveback
Journal:  J Rheumatol       Date:  1976-03       Impact factor: 4.666

4.  Behçet disease and the HLA system.

Authors:  M Takano; T Miyajima; M Kiuchi; K Ohmori; H Amemiya
Journal:  Tissue Antigens       Date:  1976-08

5.  Letter: HL-A5 and Behçet's disease.

Authors:  S Ohno; K Aoki; S Sugiura; E Nakayama; K Itakura; M Aizawa
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

6.  Behçet's syndrome with arthritis.

Authors:  R M Mason; C G Barnes
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

7.  Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants.

Authors:  J J van Rood; A van Leeuwen; J S Ploem
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

8.  HLA in Behçet's disease.

Authors:  R T Jung; T M Chalmers; V C Joysey
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

9.  The high prevalence of HLA-B5 in Behçet's disease.

Authors:  H Yazici; G Akokan; B Yalçin; A Müftüoğlu
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

10.  Behcet's syndrome in 32 patients in Yorkshire.

Authors:  M A Chamberlain
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

  10 in total
  18 in total

Review 1.  Pulmonary manifestations of Behçet's disease.

Authors:  F Erkan; A Gül; E Tasali
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 2.  Behçet syndrome: is it one condition?

Authors:  H Yazici; S Ugurlu; E Seyahi
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

3.  HLA and Behçet's disease in northern Spain: their lack of correlation with arthritis pattern.

Authors:  J Sanchez Burson; J Graña Gil; M Rosales Rodriguez; A Atanes Sandoval; C Alonso Blanco; F Galdo Fernandez
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 4.  The unique features of vasculitis in Behçet's syndrome.

Authors:  Melike Melikoglu; Emire Kural-Seyahi; Koray Tascilar; Hasan Yazici
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

5.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

6.  Behçet disease: advantageous against development of neoplasia?

Authors:  I Celík; I Barişta; G Tekuzman; E Kansu; S Kíraz; M Calgünerí
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

7.  Behcet's disease.

Authors:  Jagdish R Nair; Robert J Moots
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 8.  Interventions for the management of oral ulcers in Behçet's disease.

Authors:  Jennifer Taylor; Anne-Marie Glenny; Tanya Walsh; Paul Brocklehurst; Philip Riley; Rachel Gorodkin; Michael N Pemberton
Journal:  Cochrane Database Syst Rev       Date:  2014-09-25

9.  The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.

Authors:  T Lehner; K I Welsh; J R Batchelor
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

10.  Ankylosing spondylitis with predominant involvement of the cervical spine in a woman with Behçet's syndrome.

Authors:  I Olivieri; G Gemignani; F Busoni; F Pecori; E Camerini; D Trippi; G Pasero
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.